Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Protein Science : a Publication of the Protein Society
|
June 9, 2016
The interplay between effector binding and allostery in an engineered protein switch
Jay H Choi, Tina Xiong, Marc Ostermeier
Biotechnology and Bioengineering
|
December 31, 2010
Stability of a guest protein depends on stability of a host protein in insertional fusion
Brennal Pierre, Tina Xiong, Leonie Hayles, et al.
Plos One
|
December 19, 2018
Protein engineering strategies for improving the selective methylation of target CpG sites by a dCas9-directed cytosine methyltransferase in bacteria
Tina Xiong, Dahlia Rohm, Rachael E Workman, et al.
Scientific Reports
|
July 29, 2017
Targeted DNA methylation in human cells using engineered dCas9-methyltransferases
Tina Xiong, Glenna E Meister, Rachael E Workman, et al.
Chembiochem : a European Journal of Chemical Biology
|
September 23, 2015
Molecular Determinants for Protein Stabilization by Insertional Fusion to a Thermophilic Host Protein
Brennal Pierre, Jason W Labonte, Tina Xiong, et al.
Journal of Medicinal Chemistry
|
March 30, 2026
Discovery of Potent, Selective, CNS-Penetrant Macrocyclic LRRK2 Inhibitors for the Treatment of Parkinson's Disease
Elsie C Yu, Hua Zhou, Xin Yan, et al.
Journal of Medicinal Chemistry
|
October 20, 2023
Discovery of MK-1468: A Potent, Kinome-Selective, Brain-Penetrant Amidoisoquinoline LRRK2 Inhibitor for the Potential Treatment of Parkinson's Disease
Solomon D Kattar, Anmol Gulati, Kaila A Margrey, et al.
Journal of Medicinal Chemistry
|
September 4, 2024
Discovery and Optimization of N-Heteroaryl Indazole LRRK2 Inhibitors
Kaitlyn M Logan, Will Kaplan, Vladimir Simov, et al.
Journal of Medicinal Chemistry
|
December 30, 2021
Structure-Guided Discovery of Aminoquinazolines as Brain-Penetrant and Selective LRRK2 Inhibitors
Mitchell H Keylor, Anmol Gulati, Solomon D Kattar, et al.
Journal of Medicinal Chemistry
|
December 8, 2022
Discovery and Optimization of Potent, Selective, and Brain-Penetrant 1-Heteroaryl-1<i>H</i>-Indazole LRRK2 Kinase Inhibitors for the Treatment of Parkinson's Disease
David A Candito, Vladimir Simov, Anmol Gulati, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Protein Science : a Publication of the Protein Society
|
June 9, 2016
The interplay between effector binding and allostery in an engineered protein switch
Jay H Choi, Tina Xiong, Marc Ostermeier
Biotechnology and Bioengineering
|
December 31, 2010
Stability of a guest protein depends on stability of a host protein in insertional fusion
Brennal Pierre, Tina Xiong, Leonie Hayles, et al.
Plos One
|
December 19, 2018
Protein engineering strategies for improving the selective methylation of target CpG sites by a dCas9-directed cytosine methyltransferase in bacteria
Tina Xiong, Dahlia Rohm, Rachael E Workman, et al.
Scientific Reports
|
July 29, 2017
Targeted DNA methylation in human cells using engineered dCas9-methyltransferases
Tina Xiong, Glenna E Meister, Rachael E Workman, et al.
Chembiochem : a European Journal of Chemical Biology
|
September 23, 2015
Molecular Determinants for Protein Stabilization by Insertional Fusion to a Thermophilic Host Protein
Brennal Pierre, Jason W Labonte, Tina Xiong, et al.
Journal of Medicinal Chemistry
|
March 30, 2026
Discovery of Potent, Selective, CNS-Penetrant Macrocyclic LRRK2 Inhibitors for the Treatment of Parkinson's Disease
Elsie C Yu, Hua Zhou, Xin Yan, et al.
Journal of Medicinal Chemistry
|
October 20, 2023
Discovery of MK-1468: A Potent, Kinome-Selective, Brain-Penetrant Amidoisoquinoline LRRK2 Inhibitor for the Potential Treatment of Parkinson's Disease
Solomon D Kattar, Anmol Gulati, Kaila A Margrey, et al.
Journal of Medicinal Chemistry
|
September 4, 2024
Discovery and Optimization of N-Heteroaryl Indazole LRRK2 Inhibitors
Kaitlyn M Logan, Will Kaplan, Vladimir Simov, et al.
Journal of Medicinal Chemistry
|
December 30, 2021
Structure-Guided Discovery of Aminoquinazolines as Brain-Penetrant and Selective LRRK2 Inhibitors
Mitchell H Keylor, Anmol Gulati, Solomon D Kattar, et al.
Journal of Medicinal Chemistry
|
December 8, 2022
Discovery and Optimization of Potent, Selective, and Brain-Penetrant 1-Heteroaryl-1<i>H</i>-Indazole LRRK2 Kinase Inhibitors for the Treatment of Parkinson's Disease
David A Candito, Vladimir Simov, Anmol Gulati, et al.
Page
of 1